)
Alice Gilman, PhD
Co-Founder and COO
R3 Biotechnologies
Alice Gilman is a biotechnology entrepreneur and longevity researcher focused on advancing regenerative and replacement medicine. She is the Founder of a stealth biotech company developing new platforms for drug testing and exploring ethical applications of AI in aging research.
Alice is a Fellow and Counselor at the Longevity Biotech Fellowship and an Advisor to The Residency, an incubator backed by Sam Altman supporting emerging biotech founders. She has spoken at leading industry events including BioFuture, LSX World Congress, and Vision Weekend Puerto Rico 2025, sharing insights on the future of longevity and regenerative biotech.
Previously, Alice contributed to operations at Symbiont Labs, a deep-tech venture focused on human augmentation technologies. She holds a BA in International Relations from the University of British Columbia and a Master’s in Applied Neuroscience from King’s College London, and is currently writing a book on longevity and replacement biology.
Sessions
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}